Onoda T - Search Results

1

Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitors and Hypothyroidism: An Analysis of the Japanese Pharmacovigilance Database.

Tanaka H, Tani A, Onoda T, Ishii T. Tanaka H, et al. Among authors: onoda t. In Vivo. 2024 Mar-Apr;38(2):917-922. doi: 10.21873/invivo.13519. In Vivo. 2024. PMID: 38418113 Free PMC article.

2

Understanding the Actual Use of Anti-HIV Drugs in Japan from 2016 to 2019: Demonstrating Epidemiological Relevance of NDB Open Data Japan for Understanding Japanese Medical Care.

Tanaka H, Onoda T, Ishii T. Tanaka H, et al. Among authors: onoda t. Int J Environ Res Public Health. 2022 Sep 25;19(19):12130. doi: 10.3390/ijerph191912130. Int J Environ Res Public Health. 2022. PMID: 36231441 Free PMC article.

3

[Chemical Stability after Mixing Continuous Infusion Drugs Used to Treat Cardiogenic Shock].

Onoda T, Kinoshita M, Tanaka H, Izawa K, Urano A, Sato N, Masuda M, Ishii T. Onoda T, et al. Yakugaku Zasshi. 2022;142(11):1267-1276. doi: 10.1248/yakushi.22-00138. Yakugaku Zasshi. 2022. PMID: 36328453 Free article. Japanese.

4

Time to Onset of Gemcitabine-induced Thrombotic Microangiopathy in a Japanese Population: A Case Series and Large-scale Pharmacovigilance Analysis.

Takigawa M, Tanaka H, Washiashi H, Onoda T, Ishigami A, Ishii T. Takigawa M, et al. Among authors: onoda t. Cancer Diagn Progn. 2023 Jan 3;3(1):115-123. doi: 10.21873/cdp.10188. eCollection 2023 Jan-Feb. Cancer Diagn Progn. 2023. PMID: 36632593 Free PMC article.

5

Accuracy of Therapeutic Drug Monitoring of Teicoplanin at the Onset of Febrile Neutropenia.

Takigawa M, Tanaka H, Suwa J, Obara T, Maeda Y, Sato M, Shimazaki Y, Onoda T, Ishigami A, Ishii T. Takigawa M, et al. Among authors: onoda t. Medicina (Kaunas). 2023 Apr 13;59(4):758. doi: 10.3390/medicina59040758. Medicina (Kaunas). 2023. PMID: 37109716 Free PMC article.

6

Analysis of COVID-19 mRNA Vaccine-induced Mouth Ulcers Using the Japanese Adverse Drug Event Report Database.

Onoda T, Tanaka H, Matsuo H, Takigawa M, Satoh M, Ishii T. Onoda T, et al. Pharmazie. 2023 May 1;78(5):63-66. doi: 10.1691/ph.2023.3521. Pharmazie. 2023. PMID: 37189267

7

Characteristics of adverse event reports among people living with human immunodeficiency virus (HIV) in Japan: Data mining of the Japanese Adverse Drug Event Report database.

Tanaka H, Satoh M, Takigawa M, Onoda T, Ishii T. Tanaka H, et al. Among authors: onoda t. Drug Discov Ther. 2023 Jul 12;17(3):183-190. doi: 10.5582/ddt.2023.01007. Epub 2023 Jun 16. Drug Discov Ther. 2023. PMID: 37331810 Free article.

8

Bibliometric analysis of Kampo medicine hotspots and trends for the decade: 2013-2022.

Onoda T, Tanaka H, Ishii T. Onoda T, et al. Medicine (Baltimore). 2023 Nov 3;102(44):e35897. doi: 10.1097/MD.0000000000035897. Medicine (Baltimore). 2023. PMID: 37932994 Free PMC article.

9

Adverse Event Profile of Atezolizumab, Bevacizumab, Carboplatin, and Paclitaxel Combination Therapy Based on JADER.

Endo K, Tanaka H, Matsuo H, Onoda T, Iida A, Ishii T. Endo K, et al. Among authors: onoda t. Anticancer Res. 2024 Jun;44(6):2653-2660. doi: 10.21873/anticanres.17072. Anticancer Res. 2024. PMID: 38821611

10

Comprehensive evaluation of antioxidant effects of Japanese Kampo medicines led to identification of Tsudosan formulation as a potent antioxidant agent.

Sato N, Li W, Takemoto H, Takeuchi M, Nakamura A, Tokura E, Akahane C, Ueno K, Komatsu K, Kuriyama N, Onoda T, Higai K, Koike K. Sato N, et al. Among authors: onoda t. J Nat Med. 2019 Jan;73(1):163-172. doi: 10.1007/s11418-018-1259-x. Epub 2018 Oct 29. J Nat Med. 2019. PMID: 30374696

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

242 results

Search Page

Filters